290 related articles for article (PubMed ID: 7541677)
1. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
Timme TL; Truong LD; Slawin KM; Kadmon D; Park SH; Thompson TC
Microsc Res Tech; 1995 Mar; 30(4):333-41. PubMed ID: 7541677
[TBL] [Abstract][Full Text] [Related]
2. Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutions.
Timme TL; Yang G; Rogers E; Kadmon D; Morganstern JP; Park SH; Thompson TC
Lab Invest; 1996 Apr; 74(4):747-60. PubMed ID: 8606485
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.
Timme TL; Truong LD; Merz VW; Krebs T; Kadmon D; Flanders KC; Park SH; Thompson TC
Endocrinology; 1994 Mar; 134(3):1039-45. PubMed ID: 8119140
[TBL] [Abstract][Full Text] [Related]
6. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.
Cunha GR; Ricke W; Thomson A; Marker PC; Risbridger G; Hayward SW; Wang YZ; Donjacour AA; Kurita T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):221-36. PubMed ID: 15663986
[TBL] [Abstract][Full Text] [Related]
7. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
[TBL] [Abstract][Full Text] [Related]
8. Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model.
Hayward SW; Haughney PC; Rosen MA; Greulich KM; Weier HU; Dahiya R; Cunha GR
Differentiation; 1998 Jul; 63(3):131-40. PubMed ID: 9697307
[TBL] [Abstract][Full Text] [Related]
9. Role of stroma in carcinogenesis of the prostate.
Cunha GR; Hayward SW; Wang YZ
Differentiation; 2002 Dec; 70(9-10):473-85. PubMed ID: 12492490
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.
Timme TL; Yang G; Truong LD; Kadmon D; Park SH; Thompson TC
World J Urol; 1995; 13(6):324-8. PubMed ID: 9116750
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of transforming growth factor-alpha and transforming growth factor-beta during early human fetal prostate development.
Raghow S; Shapiro E; Steiner MS
J Urol; 1999 Aug; 162(2):509-13. PubMed ID: 10411079
[TBL] [Abstract][Full Text] [Related]
14. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells.
Story MT; Hopp KA; Molter M
J Cell Physiol; 1996 Oct; 169(1):97-107. PubMed ID: 8841426
[TBL] [Abstract][Full Text] [Related]
16. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
[TBL] [Abstract][Full Text] [Related]
17. Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation.
Ishii K; Imanaka-Yoshida K; Yoshida T; Sugimura Y
Dev Biol; 2008 Dec; 324(2):310-9. PubMed ID: 18950615
[TBL] [Abstract][Full Text] [Related]
18. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
19. Modulation of phenotype of human prostatic stromal cells by transforming growth factor-betas.
Hisataki T; Itoh N; Suzuki K; Takahashi A; Masumori N; Tohse N; Ohmori Y; Yamada S; Tsukamoto T
Prostate; 2004 Feb; 58(2):174-82. PubMed ID: 14716743
[TBL] [Abstract][Full Text] [Related]
20. Stromal cells of the human prostate: initial isolation and characterization.
Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
